Somru BioScience Revenue
Biotechnology Research • 
Charlottetown, Prince Edward Island, Canada • 21-50 Employees
Somru BioScience revenue & valuation
| Annual revenue | $3,165,535 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $10,200,000 |
| Total funding | $4,400,000 |
Key Contacts at Somru BioScience
Mohammed Moin
Chief Executive Officer
Dihan Ahsan
Director Corporate Services
Company overview
| Headquarters | 19 Innovation Way, BioCommons Research Park, Charlottetown, Prince Edward Island C1E 0B7, CA |
| Phone number | +19023674322 |
| Websites | |
| NAICS | 541714 |
| Keywords | Pharmacokinetics, Biomarkers, Biosimilars, Bioassays, Bioanalytical Testing, Immunogenicity, Assay Development & Validation, Large Molecule Bioanalysis, Ai Powered Lims System, Aegyris™, Amplatto™, Gene Therapy & Immuno-Oncology, Immunoassays & Cell-Based Assays, Intelli.B™, Maby™ |
| Founded | 2012 |
| Employees | 21-50 |
| Socials |
Somru BioScience Email Formats
Somru BioScience uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@somrubioscience.com), used 70% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@somrubioscience.com | 70% |
{first initial} | j@somrubioscience.com | 15% |
{first initial}.{last name} | j.doe@somrubioscience.com | 10% |
{last name} | doe@somrubioscience.com | 5% |
About Somru BioScience
Somru BioScience is a forward-thinking contract research organization (CRO) redefining drug development with technology-driven and AI-powered solutions. At the forefront of innovation, Somru BioScience combines advanced science and cutting-edge platforms to support pharmaceutical and biotech partners across all phases of development. Central to its offerings is Aegyris, an AI-driven platform designed to streamline and optimize data analysis, accelerating decision-making in drug development. Complementing this is Amplatto, an ultrasensitive analytical platform enabling precise quantification and detection of therapeutic molecules, and Intelli.b, a revolutionary biologics fingerprinting solution that delivers unparalleled insights into molecular characteristics, supporting biosimilar and biologics development. Somru BioScience also provides an extensive range of services, including pharmacokinetics (PK), immunogenicity, biomarker analysis, and cell-based assays. Its expertise extends to assay development, validation, and sample analysis under non-GLP, GLP, and GCP standards. With a team of highly skilled scientists and quality assurance professionals, Somru BioScience is committed to scientific excellence, data integrity, and regulatory compliance. By leveraging AI and advanced analytical platforms, Somru BioScience empowers its partners with transformative tools and insights, ensuring faster, more reliable outcomes in diverse therapeutic areas.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Somru BioScience has 22 employees across 6 departments.
Departments
Number of employees
Somru BioScience Tech Stack
Discover the technologies and tools that power Somru BioScience's digital infrastructure, from frameworks to analytics platforms.
WordPress themes
JavaScript libraries
WordPress plugins
WordPress plugins
JavaScript libraries
WordPress plugins
JavaScript libraries
JavaScript libraries
Maps
Page builders
JavaScript libraries
Font scripts
Australia
United Kingdom
Czechia
Egypt
Jordan
United States
Frequently asked questions
4.8
40,000 users
